Cargando…
Oral ethinyl estradiol treatment in women with cystic fibrosis is associated with lower bone mineral density
OBJECTIVE: The purpose of this study was to determine whether estrogen supplementation primarily from oral contraceptive pills compared to no estrogen supplementation is associated with differences in mean bone mineral density (BMD) measured by DXA in a cross-sectional study of women with cystic fib...
Autores principales: | Wu, Malinda, Hunt, William R., Putman, Melissa S., Tangpricha, Vin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109452/ https://www.ncbi.nlm.nih.gov/pubmed/32257821 http://dx.doi.org/10.1016/j.jcte.2020.100223 |
Ejemplares similares
-
SUN-337 Low Dose Ethinyl Estradiol in Women with Cystic Fibrosis Does Not Preserve Bone Mass
por: Wu, Malinda, et al.
Publicado: (2020) -
Findings from a feasibility study of estradiol for hypogonadal women with cystic fibrosis-related bone disease
por: Wu, Malinda, et al.
Publicado: (2021) -
SUN-LB72 The Relationship Between Estrogen Exposure and Bone Health in Women With Cystic Fibrosis
por: Arora, Neha, et al.
Publicado: (2020) -
Use of estrogen supplementation is associated with higher quality of life scores in women with cystic fibrosis
por: Wu, Malinda, et al.
Publicado: (2021) -
Correction of the Gene Defect in Cystic Fibrosis: Is It Too Late for Bone?
por: Tangpricha, Vin
Publicado: (2021)